Undervalued US stocks

The earnings rise is real in the reported numbers — 22.7% comparable sales plus 7.9% more stores roughly tripled operating income to $154.2 million — but the supplied documents prove the result far better than they prove management's explanation of it, and the margin story rests on one extraordinary quarter that… The Q2 FY2026 report (quarter ending about August 1, 2026, expected around late August/early September 2026): if comparable sales come in below the guided 7% floor or net income below the guided $64 million, the Q1…

The earnings rise is real, broad-based and cash-backed — payment volume grew 92% year-on-year in the June 2026 quarter and the March free-cash-flow dip reverted exactly as management promised — but the take rate is compressing fast enough that first-half operating profit grew only 15% against full-year guidance of… This read is wrong if the Q3-2026 earnings release (expected ~November 2026 on EDGAR) shows the 2H26 operating leverage failing — specifically, full-year operating profit growth tracking below the 27.5% guidance floor…

The earnings rise is real — 13% revenue growth and a 24.3% GAAP operating margin are confirmed in official results with $1.95B of cash and an undrawn revolver — but the press releases document the recovery better than they explain it (no sourced cause for the 590bps margin jump), and growth has decelerated from 22% to… Year-over-year revenue growth below roughly 8% for two consecutive quarters, or GAAP operating margin falling back below roughly 15%, in results reported through the Q3-2026 earnings release (expected late October 2026)…

A genuine cash machine: 8Q OCF/PAT 135%, OPM 37→46.5% while revenue nearly doubled in 13 quarters (329→618, Q1-26 +21% YoY), net cash $1.9B, share count +1.5% with buybacks running. This A-grade is wrong if revenue growth decelerates below ~8% YoY for 2 straight quarters (volume cycle turning) or the Dec-25 +$236M non-op item turns out to be a recurring accounting re-measurement that has been…

The cleanest funding profile in the batch: net cash +$200M, zero net debt issuance, $3.2B of 8Q buybacks shrinking diluted shares, and revenue ACCELERATING 12 straight quarters (+8.7% -> +18.4% YoY) with OPM up from 21.4% to 25.2% (first4 vs last4 avg) — the FY24-25 billing-model transition noise has fully washed… This read is wrong if revenue growth decelerates below ~12% (AI seat-erosion showing up in the numbers, making 36x expensive) or if the Apr-26 NI spike (+223% YoY, aided by lapping the Apr-25 restructuring-charge…

The earnings jump is real and management has proven why — gross margin expanded from 40.5% to 51.1% (GAAP, year-over-year in the June 2026 quarter) through revenue-mix optimization and cost/productivity execution, confirmed across two guidance cycles — but it happened on shrinking revenue, and the forward story is now… Two measurable conditions would break this read: (1) the Skyworks merger is blocked or terminated (watch the FTC Second Request process and the exchange offers open until September 1, 2026), which removes the forward…

The operating recovery is real — revenue up 31.9% with operating income up from US$14.3 million to US$137.2 million in the newest quarter — but roughly three-quarters of the headline profit is mark-to-market investment gains that management itself calls fluctuations, and the press releases name the businesses driving… If other income, net falls back under roughly US$50 million per quarter in the next two reported releases (Q2 FY27 expected late October 2026 and Q3 FY27 expected late January 2027, based on the company's release…

The earnings rise is real and explained: Q2 2026 GAAP EPS rose to $0.70 from $0.57 on 4.3% organic sales growth and a record 18.3% adjusted EBITDA margin, and management's stated drivers (share gains, pricing, mix, productivity) match the segment-level numbers — but GAAP profit remains far below the adjusted figures… This read is wrong if full-year 2026 adjusted EPS comes in below $3.10 (the bottom of the raised guidance) or if Q3 2026 organic sales growth turns negative — either would show that the record-margin, share-gains story…

Franchise-royalty staircase that never broke: NI up 8/8 YoY quarters, OPM 26.1%→30.0% (first4 vs last4 avg), revenue re-accelerating to +21.9% YoY (Mar-26) on the pricing reset, and cash conversion at 199% OCF/PAT with SBC a trivial 2.8% of OCF. This read is wrong if revenue growth falls back below ~8% for 2+ quarters (pricing-reset benefit exhausted, member growth stalling) or interest expense (already −$26.7M/q, 37% of pretax drag vs opinc) rises while OCF…

The earnings step-up is real — the completed all-stock CrossFirst merger roughly doubled the bank, and the one readable document shows the margin and cost engines working (deliberate runoff of $794.6 million of 4.45%-cost deposits, synergies on track, charge-offs at 0.17%) — but with only one quarter of management… Net charge-offs above roughly 0.40% annualized (versus 0.17% in Q3 2025) or classified assets above roughly 8% of capital for two consecutive quarters through 2026 — driven by provision expense or charge-offs in the…

The dilution flag in the dispatch is DISPROVEN — CTSH is the opposite: diluted shares 513M -> 477M (-7.0% over 14Q), $2,294M repurchased over 8Q plus a $1,163M single-quarter buyback in Jun-26 (~4% of mcap in 90 days). The A-grade is wrong if revenue growth turns negative YoY or OPM drops below 14% for 2 consecutive quarters (AI deflation finally hitting seats/pricing), or if buybacks become majority debt-funded while OCF shrinks …

The earnings rise is real and cleanly explained — commercial title revenue (up 34–48% year over year) and deposit-driven investment income are lifting revenue and title margins even as the core residential order count shrinks — but only two quarters of sourced management commentary exist, so the qualitative record is… If U.S. commercial revenue posts a year-over-year decline (or average commercial revenue per order falls back toward $15,000) while residential direct order counts keep falling, the only proven growth engine is gone…

Cash conversion is real (8Q OCF/PAT 105%, ~133% ex-one-off) and funding is shareholder-friendly (shares −0.3% over 13Q, $1.4B bought back in 4 quarters), but the earnings staircase is partly an accounting artifact: ASC-606 upfront license recognition makes quarters lumpy (Sep-25 OPM 48.5%), the Mar-26 EPS of 4.98 is… This B-grade is wrong (up) if deferred revenue returns to YoY growth and the Jun-26 income quarter (once loaded) shows operating NI ≥ prior year — then the deferred-rev dip was divestiture-perimeter noise and this is an…

The earnings rise is real and well-explained: a deliberately disclosed 2024 balance-sheet repositioning plus falling deposit costs lifted net interest margin from 1.88% to 2.42% over five quarters while credit costs fell, but only two usable documents cap confidence in the record. Net interest margin fails to rise for two consecutive quarters (flat or down QoQ) while non-performing loans climb past roughly 0.6% of gross loans — that would show the deposit-repricing tailwind is spent and NJ CRE…

The earnings rise is real and well-explained — underwriting income grew because net earned premiums rose on higher reinsurance retention while catastrophe losses fell and prior-year reserves developed favorably, and investment income compounded on cash-flow-driven portfolio growth — but the gross premium top line is… This read is wrong if the next quarterly release (Q2 2026, expected late July 2026 on the company's IR site) shows ex-Commercial-Property gross written premium growth turning negative year over year, or a combined ratio…

The graph is a genuine earnings staircase — revenue +17.4% TTM, PBT +51%, 146% cash conversion, negligible SBC, debt flat on growing equity — yet the price halved via two discrete crash days (Feb-4-26 −17.6%, May-27-26 −12.5%). this read (B, not A) is wrong if the Jun-26 quarter prints revenue growth still >=12% YoY with OPM >=18% and no charge — that would prove the crashes were multiple compression, upgrade to A; conversely wrong the other…

The −94% 'price crush' is not pessimism — it is the Chapter 11 old-equity wipeout; post-reorg this is a rallying stock, so the screen's depressed-price premise is void. This B-grade is wrong (up to A) if op margin holds ≥16% through two more quarters WITH fuel/FX normalizing, buybacks continue, and the total non operating income lines resolve as recurring FX noise rather than one-off…

The earnings rise is real in the filed numbers — revenue up roughly 25% and net income up in each of the last four quarters — and management says it comes from winning market share while home sales sit at 30-year lows, but with no earnings-call transcript and only one commentary document, that explanation rests on a… This read is wrong if the Q3 2026 10-Q (expected around early November 2026, based on the prior-year filing that showed an October 30, 2025 share-count date) shows revenue growth slowing below roughly 10% year over year…

What broke is SPECIFIC and regulatory: the mortgage-score franchise lost its guaranteed monopoly (FHFA opening conforming mortgages to a rival score) plus political pressure on FICO's aggressive royalty hikes — while the numbers show the pricing power still working (Mar-26 revenue +38.7% YoY at 58.2% OPM, 121% cash… this read is wrong if scores revenue growth stays >=20% YoY for 2 more quarters WITH no regulatory cap enacted and rival-score mortgage adoption staying negligible — then the pessimism was generic headline fear and this…

The 2025 earnings rise was real and well-explained — new electrophysiology product ramps, two coatings acquisitions and neurovascular demand — but the question has changed: KKR signed a definitive agreement on August 3, 2026 to pay $127 a share in cash, so this stock is now a bet on deal completion, not on the… The deal-based read is wrong if the KKR transaction terminates — a failed stockholder vote, a regulatory block, or a financing collapse would return the stock to standalone fundamentals, where two straight quarters of…

The operating improvement is real but modest — revenue rose 8.5% and operating income 6.6% in the latest quarter — while the headline profit tripling came mostly from a one-time $835.2 million equity investment gain, not from operations. If the 10-Q for the quarter ending September 30, 2026 (due around end of October 2026) shows pre-tax profit excluding equity investment gains declining year over year while quarterly net interest expense exceeds roughly…

A real operating-leverage inflection dressed in SBC: gross margin 65.5%→79.8% and OPM -21.3%→+9.6/16.5% over 13 quarters while revenue compounds +8-12%, and the Dec-quarter PAT staircase (3.2→6.8→9.8) is a repeating seasonal shape, not one-offs. this read is wrong if revenue growth decays below ~5% YoY (operating leverage runs out of top-line to lever), if the Dec-26 holiday quarter fails to grow PAT YoY breaking the staircase, or if SBC stays at ~$16-17M/yr…

The graph is a real compounding machine at the CASH level and a treasury illusion at the GAAP level: 8Q OCF/PAT is 417% ($717.1M vs $172.1M), but cumulative 8Q OPERATING income is just $2.0M — treasury interest ($10-18M/q, >25% of pretax in 7 of the last 8 quarters, 118% in Sep-25) plus a one-off $60.8M Dec-25 tax… This B(+) is wrong if revenue growth decays below ~15% YoY, if operating margin slips back negative for 2+ quarters (proving the P&L never escapes treasury dependence), or if buybacks stop while SBC stays >$150M/yr so…

The earnings jump is real in the filings — a completed merger plus merger-charge roll-off — but the evidence window contains no management explanation of the quarterly drivers and no forward target to test, so the qualitative case rests on the reported numbers alone. If the Q2 2026 10-Q shows quarterly provision for credit losses above roughly $30 million for a second straight quarter, or OREO continuing to climb from its $26.1 million level, the merger imported credit problems and…

Classic combined-ratio-recovery shape: the single loss quarter (Q2-24, EPS -1.08) was the casualty reserve strengthening, and every quarter since is a clean staircase — annual netinc company 365.2 (2023) → 207.0 (charge year 2024) → 466.3 (2025, +28% above the pre-damage level), with premium revenue up every single… this read is wrong if fresh adverse casualty reserve development appears in any 2026-27 quarter, or renewal pure-price drops below loss-cost trend (combined ratio back toward 100 — Q2-24-style earnings air pocket…

The loss-to-profit staircase is real cash (8Q OCF/PAT 364%, OCF scaled 11→85/qtr) but roughly half the NI swing is interest-expense refi after the IPO repaid $909M of LBO debt, not operating improvement, and the last two quarters' step-up rides a ~$1.5B Dec-25 acquisition (goodwill +$997M, +$390M debt, +16M shares). This B-grade is wrong (up) if the next 2 quarters show organic revenue growth ≥12% ex-acquisition with OPM ≥24% and net debt falling — then the curve is a compounder mispriced by IPO overhang; wrong (down) if OCF/qtr…

The earnings rise is only partly real: revenue growth of roughly 14% year over year and strong operating cash flow are genuine, but headline profit is dominated by a one-time Q4 2025 gain — the accumulated deficit improved by about $2.76 billion in that single quarter — and GAAP operating profit slipped back to a… This read is wrong if GAAP operating margin, excluding one-time items, falls back below -3% of revenue for two consecutive quarters over the next two to three quarters, or if quarterly operating cash flow drops below…

A genuine cash machine wearing a China discount: 8Q OCF RMB 8,379.5M vs PAT 5,141.6M = 163% conversion, operating margin exploded 12.0% -> 31.5% (first-4 vs last-4), and net cash RMB 20.4B (~$2.85B) is 39% of the entire market cap. The B-grade (and the opportunity read) is wrong if revenue growth goes below ~+3% YoY or op margin rolls over below 25% for 2 straight quarters (the cycle risk realizing), or wrong upward if revenue re-accelerates past…

In R$ the graph is a flawless staircase: revenue 1,400.5→2,441.0 (+74%) and PAT 194.9→417.5 (+114%) over 9 quarters, PAT up SEQUENTIALLY 8 of 8, ROE climbing 9.1%→16.0% annualized with pretax margin steady ~19.5% and book value +21% self-funded on only +4.6% share creep — while the ADR is −48.4% off its high and fell… this read is wrong if provisioning/credit cost is deteriorating beneath the aggregate cor line (a provisions check from the actual filings showing coverage falling while the loan book grows would break the staircase's…

The curve (corr 0.11 — shape weak, judged on numbers) is a cost-out margin staircase on a flat-to-declining top line: FY revenue 3,310→3,200→3,129 while peak-quarter OPM went 8.6%→11.0%→11.8%→12.6% (Mar quarters) and FY PAT 125.6→107.9→162.8. this read is wrong if the Mar/Jun-2027 seasonal peak quarters fail to grow PAT YoY, or revenue decline steepens past -5% (cost-out is the whole story and it exhausts), or buybacks stop while the Dec/Sep loss quarters…

The fiscal 2026 earnings jump is only partly real operating improvement — acquisitions added $44.1 million of quarterly sales and Consumer Products margins genuinely rose — but most of the headline GAAP jump (diluted EPS $0.08 to $0.97) comes from lapping a $52.2 million prior-year write-down, adjusted EPS actually… Equity income from unconsolidated affiliates falls below roughly $25 million for two consecutive quarters (it was $38.1 million in Q4 FY26), or Building Products adjusted EBITDA declines again in FY27 despite…

The graph shows a business whose revenue has gone nowhere in three years — 308.6M in Q2-2023 vs 310.2M in Q1-2026, with a dip to 291.5M mid-2024 — while operating margin held ~19% and GAAP PAT recovered from a -24.4M loss quarter (Q2-2024) to ~30M/quarter. This read is wrong if quarterly revenue breaks below the 2024-06-30 trough of 291.5M within the next two to three reported quarters — that would confirm the annuity is actually melting, and a 31% FCF yield on a…

The Marks question was specific-vs-real damage, and the P&L answers it: through the autumn-2025 Tylenol political attack, revenue GREW +3.2% then +4.5% YoY and Mar-26 delivered the best quarter since the spin (netinc company 474, +47% YoY, OM 19.6% series high) — the damage was headline-specific, not demand-specific… this read is wrong if litigation converts from headline to material liability (a reserved settlement or adverse verdict — the discount was right), or if revenue growth slips back below zero for 2 consecutive quarters…

The earnings rise looks real — revenue and profit growth is driven by measurable customer and volume growth plus a disclosed, deliberate take-rate trade-off — but the qualitative record here covers only two of the last four quarters, so conviction is capped. This read is wrong if the Q2 FY27 results (due around mid-November 2026 via the company's SEC 6-K and owners.wise.com) show constant-currency net revenue growth below 15% or an income before tax margin trending below…

The graph the screen matched (PAT corr 0.91 to Atul) is real cash underneath - 488% OCF/PAT conversion, SBC negligible - but the staircase is manufactured by deleveraging (interest -111/q to -73/q on 752m of debt repaid from cash) plus ~0.8pp of merger-synergy margin, on a top line that is organically FLAT… this read is wrong toward A if organic revenue turns >=+3% YoY for 2 straight quarters with OPM >=5% (synergies + book-to-bill working) while debt keeps falling ~150m/q; wrong toward C if federal…

The earnings rise is real in the reported numbers — subscription revenue up double digits with operating income also up — but the evidence window contains only numeric 10-Q filings with no management commentary, so neither the cause of the growth nor management's track record on promises can be verified from these… This read is wrong if the FY27-Q2 10-Q (expected around August-September 2026) shows subscription and support revenue growth, excluding acquisitions, below roughly 6% year over year, or shows operating income declining…

The earnings recovery is real — revenue, operating income and operating cash flow all grew across the four quarters, and management's segment-level explanations match the filed numbers — but the headline Q1-2026 profit spike rests on a one-time $225.5M gain on acquiring control of its Mexico affiliate, and roughly 3… FY2026 organic constant-currency revenue excluding the FICO mortgage royalty comes in below the guided +5% to +6%, or the FICO Mortgage Direct License Program diverts mortgage volumes — either would show the growth…

The double-digit revenue growth is real and product-level proven (DAYBUE +30% on the STIX launch, NUPLAZID growing on a bigger sales force), but the headline profit staircase is mostly tax accounting, and the operating engine is currently being squeezed by a 35%-type SG&A build whose payoff is still pending. This read is wrong if full-year 2026 revenue lands below the raised $1.24 billion guidance floor or the company posts a full-year operating loss - i.e., DAYBUE STIX uptake stalls below the $480M guide and the SG&A build…

The 4.2x PAT curve (TTM 294.3 vs prior-4Q 70.6, $m) is roughly HALF deleveraging math, half operations: of the +88.3 pretax swing Sep-24→Mar-26, +43.2 is interest expense falling (−81.4→−38.2/qtr after the IPO paid debt from 3,611 to 2,453) and +45.0 is operating income (98.1→143.1 on revenue +31% and OPM 7.6%→9.0%). this read is wrong if OPM breaks decisively above ~10% for 2+ quarters (engine-MRO supercycle pricing power exceeding the deleveraging framing) while sponsor sell-downs complete without price damage — then the growth is…

The earnings rise is real in the reported numbers — Q2 2026 net income of $135.9 million versus $87.4 million a year earlier, helped by lower credit provisions, lower operating expenses and a shrinking share count — but with only one management commentary document in the window, the causal story rests on a single… The read is wrong if the 2025 loan vintage's forecasted collection rate falls materially below its 67.0% initial forecast (variance worse than about minus 2%), or if any single quarter shows a decrease in forecasted net…

Everything about the business is real — 100.3% 8Q cash conversion, 12.9% SBC, disciplined post-NFP deleveraging (18.3B to 15.7B) with buybacks stepping 250 to 600m/q — but the Marks question is what is priced in, and the answer is: full value. this B-not-A is wrong if organic revenue growth re-accelerates above 9-10% for 2 straight quarters with OPM expanding (NFP synergies landing late) while the multiple stays ~23x — that would create genuine compounding…

A genuinely good roll-up — 279% OCF/PAT, SBC 3.3% of OCF, dividends covered — but it is the WRONG SETUP for this exercise and the honest answer to the price-leg question is no: at −16.6% off its 3y high and +30.4% above its low, on ~40.7x TTM GAAP earnings, nothing is depressed. This C-for-setup read is wrong if price-cost spread re-accelerates (OPM back above 18% with revenue growth back above 8% for 2+ quarters) while the price stays under ~$150 — that would create the asymmetry that is…

The NI staircase the screen matched (netinc company 49.8→122.2 in 4 quarters, +145%) is mostly bought: shares went 74.7M→142.3M (+90%) across two stock acquisitions, and EPS 0.84 has only just cleared the Dec-22 pre-deal 0.90. this read is wrong if TBVPS growth stalls below ~8%/yr or provisions mean-revert sharply upward once loan-mark accretion fades (the 2.2-2.7/q provision era proves flattered, EPS run-rate breaks), or — on the upside — if…

The headline curve is manufactured by deal accounting: FY25 netinc company 591.1 vs FY24 67.6 (~8.7x) but Dec-25 alone is 350.0 on a 29.4% operating margin against 7-9% in every normal quarter — a divestiture gain (ncfi +611.8 same quarter), and FY24's base was depressed by deal costs (Dec-24 loss -56.7). this read is wrong if ex-gain quarterly EPS (the 0.68-1.23 band) steps decisively above ~1.30 on organic revenue growth — that upgrades it toward A; the B-grade itself breaks DOWN if deleveraging stalls above ~4.5B debt…

The 2025 run-up was a cloud/GenAI re-rating on genuinely strong cash (FCF TTM 492m, 10.9x mcap/FCF, converts repaid, now net cash); the -51% crush that followed is anchored to something specific: Mar-26 revenue fell 9.6% YoY and the two latest seasonal OPM pairs contracted -8.4pp and -18.1pp, so the market is saying… this read is wrong toward A if Dec-26 and Mar-27 print YoY revenue growth >=10% with OPM back at or above the year-ago pair - that would prove Mar-26 was ASC-606 license timing, not demand; wrong toward C if revenue…

The staircase is a genuine recovery — revenue 126.6→310.0 ($M, Mar-24→Mar-26) as P&C carrier ad-spend came back, op margin −20%→+7%, and cash conversion is real (8Q OCF/PAT 168%). But the P&L is noisy: two loss quarters in the last 8 (Jun-25 −22.5 incl. This B is wrong (too harsh) if Q2-2026 income confirms ~$40M quarterly net income at positive equity and SBC/OCF falls below 30% — that would be an A-shaped inflection; wrong (too kind) if revenue growth decays below…

The crash was specific damage - offshore-wind writedowns (Dec-23 -$1.29B, Sep-24 -$116M) - and the damage looks DONE: wind exited in 2024 and the last 5 quarters are clean regulated earnings growing ~10% YoY on 21-24% op margins. This read is wrong (up to A/B+) if two more clean quarters pass with FCF sustainably positive (Mar-26 +$315M repeated) and equity issuance stops - that would mean the Aquarion-funded capex plan self-finances; wrong…

The staircase is a margin-recovery story at a leveraged fee-services roll-up, not a growth story: 8Q OCF/PAT is 276% ($130.1M vs $47.1M) but SBC is 53.6% of that OCF and two of the last 5 quarters printed negative OCF (Mar-25 −$4.7M, Sep-25 −$8.6M). This B is wrong (up) if revenue re-accelerates >10% YoY for 2 straight quarters WHILE net debt falls both quarters and OCF stays positive; wrong (down to C) if Dec-quarter revenue decline extends to 2 consecutive YoY…

REIT caveat first: GAAP NI understates tower economics (D&A-heavy) and our DB has no FFO/AFFO, so every sub-score here is conservative by construction. this read is wrong if OCF returns to growth for 2+ quarters (carrier capex/5G densification re-accelerating leasing revenue above the ~3%/yr escalator crawl) — then the stagnation assumption breaks and 15.7x OCF with a…

The graph shows a real operating inflection — 13 straight quarters of sequential revenue growth, OPM from -43% to +5.2%, true PAT improving 8/8 YoY and crossing zero — but the profitability is economically hollow: 8Q SBC of 131.1m equals 96.5% of the 135.8m OCF, cumulative 8Q GAAP PAT is still -33.5m, and shareholders… this C is wrong if SBC/OCF falls below ~50% within 3 quarters while revenue growth holds >=12% and GAAP PAT keeps rising — that would mean true ops leverage is outrunning the comp bill and the 10x headline FCF becomes…

The earnings improvement is real in the filed numbers — revenue up 21.5% year-over-year and operating income swinging positive — but the supplied filings contain no management explanation or guidance for it, so the qualitative 'why' rests almost entirely on the arithmetic of subscription revenue growing faster than… If cumulative operating cash flow over the next two reported quarters (through September 30, 2026, checkable in the Q3 FY26 10-Q expected on SEC EDGAR around November 2026) annualizes below roughly $60M, the…

The reported quarters show a genuine margin and cash-flow recovery, but every document supplied is a filing shell with no management explanation, no forward driver and no promise history, so the qualitative 'why' behind the earnings rise is unverified rather than proven. This thin-history read becomes wrong — and the recovery thesis with it — if the FY26-Q4 filings and call transcript show revenue still declining year over year with operating margin falling back below 10% and shrinking…

The staircase is three-quarters treasury: over 8Q, non-operating income ($814.5M — interest on the $8.4B meme-raised pile plus BTC/investment marks) is 76.6% of cumulative pretax, and the latest blowout quarter ($389.6M NI) contains $83.7M interest + $279.4M investment marks + a $116.8M tax BENEFIT — strip those and… This C is wrong if operating income stays >$100M/quarter for the next 2 quarters with gross margin >=38% AND revenue grows YoY in both — that would prove the collectibles mix is a durable business, not a card-mania…

The earnings jump is real as reported — a 17.5% gross-margin quarter with $1,178M net income — but it is one preliminary, unaudited quarter, explained only by management's enterprise-mix story, sitting on a full year of negative operating cash flow funded by debt and new equity, with two missed revenue guides behind… The Q1 FY27 report (quarter ending September 30, 2026, expected around November 2026 on the IR quarterly-results page): if net sales come in below the $14.5 billion low end of guidance, or gross margin falls back below…

This is not a depressed earnings staircase - it is former US Cellular liquidating: wireless sold to T-Mobile (+2,596 ncfi Sep-25), spectrum to AT&T/Verizon (+1,004 Mar-26), an $885m / ~$10.24-per-share special dividend out, leaving a ~$210m-revenue tower stub whose 3 post-sale quarters show CUMULATIVE OCF of -260 and… the C is wrong if the tower stub prints 2 consecutive quarters of positive OCF and positive operating income EX-gains with tower revenue holding >=55m/q and growing - then a clean small tower-lessor at ~3.0B mcap merits…